So Haslehurst is in for $4,400! and vol goes >34 mill! Does he also report when he sells? He's up $200 so far.Don't Hoff the Hasle!!
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress